Menu ×

HEALTHCARE & PHARMACEUTICAL

Biopsy Devices Market Analysis By Product Type (Needles, Vacuum-Assisted Devices, Syringes, Forceps And Others) By Application (Bone Biopsy, Breast Biopsy, Liver Biopsy, Kidney Biopsy, Prostate Biopsy And Others); By Guidance (Computed Tomography (CT), Stereotactic, Fluoroscopy, Ultrasound, MRI-Guided And Others); By End User (Hospitals, Diagnostic And Imaging Centers, Medical Clinics And Others) – Global Demand Analysis & Opportunity Outlook 2028

  • Text Size:

Extensive insights into the Growth of Biopsy Devices Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More
IN THE NEWS
  • On October 1,2018, CeCaVa – Centre for Cancer Vaccines, a joint venture by the German medical technology and pharmaceutical giant B. Braun Melsungen AG, was setup in Tübingen, Germany. This allowed both the companies to expand their businesses in the field of cancer vaccines.

Introduction to Biopsy Devices

In Medical Sciences, a biopsy is a test performed by doctors and surgeons involves the procedure of extracting sample cells or tissues for examining the presence or extent of disease such as Cancer.There are two types of biopsies – incisional and excisional. incisional biopsy – also called core biopsy is the process of removal of a portion of the abnormal tissue, while excision biopsy is the procedure where an entire lump of suspicious tissue is surgically removed.Bone biopsy, breast biopsy, kidney, lungs and others are the most common biopsies performed.To perform these biopsies various surgically operable instruments such asneedles, syringes, vacuum-assisted devices and forceps and others are sterilized properly and used. Under the guidance of Ultrasound or a CT scan the areas of abnormal tissues are identified and the removal is done.Several types of needles are used for different purposes.

A fine needle is attached to syringes in order to draw blood while a core needle, also called spring loaded needle is attached to a spring-loaded mechanism and operated. Generally these needle biopsies are performed with the guidance of CT, Ultrasound or MRI.A vacuum-assisted device (VAD) is an instrument that applies pressure and pulls the tissue into the needle.Inradinc.SelectCoreTM Variable Throw Biopsy Device, HologicSertera® Biopsy device and Pink AchieveTM Biopsy Device are some of the biopsy devices available in the market.

Market Size and Forecast

Increase in carcinogenic agents and particulates in food, air, the prevalence of cancer globally and the high mortality rates among the old people are some of the significant factors boosting the market growth. The availability of biopsy devices for identification of tumorsof cancer related ailments likelung carcinoma, skin cell carcinoma and other cancers is estimated to boost the market growth for the forecast period.Based on product type, the market is bifurcated into needles, vacuum-assisted devices, syringes, forceps and others, out of which, the highest market share is estimated to be held by vacuum assisted devices. This can be attributed to the ease of operability and availability in the market. The market is further segmented by application into breast biopsy, lung biopsy and other cancer treatments. Additionally, the effectiveness of the devices in locating the tumor and removal with surgical precision is high, making them the most preferred devices by surgeons. This is another factor estimated to contribute to the growth of the market. CLICK TO DOWNLOAD SAMPLE REPORT

Growth Drivers

Prevalence of Cancers amid Ageing Population

World Health Organization reported that Cancer is the number 2 cause of death globally and estimated 9.6 million deaths in 2018.Moreover, it estimated that between 2015 and 2020, the proportion of world’s population over 60 years will nearly double from 12% to 22%. Production of biopsy devices for early identification of cancer will help in controlling the mortality rates. This factor is anticipated to have a significant positive influence on the growth of the market.

Overweight, Obesity and Work patterns

It was reported by IHME, that in 2017, 4.7 million deaths globally were caused by obesity and majority of the cases were reported in urban areas of the world where reduced activity and poor diets are attributed to accelerate the rise of it. Working hours and lifestyle patterns are leading to mental ill-health which is resulting in significant rise in cases of depression, stress, anxiety, eating disorders leading towards cigarettes, alcohol or drugs.

The WHO reports that 300,000 children aged 0 to 19 years are diagnosed with cancer every year.A study published by National Cancer Institute, U.S. Department of Health and Human Services, points out that Obesity & Overweight is predicted to increase the risk of cancerssuch asendometrial cancer, gastric cardia cancer, meningioma, colorectal cancer and others.The risk of Cancer in this population demography is estimated to drive the growth of biopsy devices market positively.

COVID’19 and its aftermath

WHO as of May 6th 2020, reported that the death toll among COVID-19 patients is high in cases where patients are suffering from various other illnesses like pneumonia, coronary heart diseases, cancers and others prior to COVID’19.The treatment for the patients suffering from cancers and later affected by COVID’19 involves the use of ventilators and biopsy devices. This results in healthcare professionals urging the governments to provide them the biopsy devices for proper treatment.

Restraints

High costs to Impact the Market Growth

A major factor that is estimated to affect the growth of the market is the high cost associated with biopsy devices, which makes them unaffordable for a large section of the society.

Market Segmentation

Our in-depth analysis of the biopsy devicesmarket includes the following segments:

By Product Type

  • Needles
  • Vacuum assisted devices
  • Syringes
  • Forceps
  • others

By Application

  • Bone Biopsy
  • Breast Biopsy
  • Liver Biopsy
  • Kidney Biopsy
  • Prostate Biopsy
  • Others

By Guidance

  • Computed Tomography (CT)
  • Stereotactic
  • Fluoroscopy
  • Ultrasound
  • MRI
  • others

By End User

  • Hospitals
  • Diagnostic and Imaging Centres
  • Medical Clinics
  • Others

By Region

On the basis of regional analysis, the biopsy devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to hold the largest share in the market on account of presence of leading market players in the region which manufacture and market the biopsy devices. The prevalence ofobesity among all ages, andincreasing alcohol consumption and smoking among adults is which eventually leadsto cancers and related illnessesin this region, increases the demand for this product. The market in Asia Pacific region is predicted to grow at the highest rate during the forecast period as a result ofrising prevalence of cancer in countries such as India and China on account of ageing population, rising air pollution levels and related illnesses and need for early stage cancer detection.

Image

The biopsy devicesmarket is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market

  • ARGON MEDICAL
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved